Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxindole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102659494A discloses a novel organocatalytic route for 3,3-disubstituted-2-oxindoles, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Advanced base-catalyzed synthesis of 3-hydroxy-2-oxindole intermediates. Delivers high purity, scalable production, and significant cost reduction for pharmaceutical manufacturing.
Patent CN111848322B reveals a novel resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate supply chains.
Patent CN102659494B details a novel chiral organic catalytic method for high-purity 3,3-disubstituted-2-oxindoles, offering significant cost and supply chain advantages.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Novel oxindole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions for fine chemical manufacturing.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral styrenes. Discover cost-effective, high-ee synthetic routes for pharmaceutical intermediates.
Patent CN115215783A details a novel copper-catalyzed synthesis of chiral propargyl-substituted oxindoles, offering high stereoselectivity and cost reduction in API manufacturing.
Novel cobalt-catalyzed asymmetric Friedel-Crafts reaction for high-purity oxindoles. Cost-effective alternative to noble metals with scalable production capabilities.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Patent CN108409630B reveals a green aqueous method for 3-hydroxy-2-indolones using t-BuOOH, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel Cu-catalyzed synthesis of spiro[β-lactam-3,3'-oxindole] derivatives with high yield and antiviral activity. Cost-effective pharma intermediate manufacturing.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method yielding high-purity axially chiral oxindole-substituted styrenes for asymmetric catalysis applications.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Novel asymmetric synthesis method enables high-purity chiral spiro pyrrolidine oxindole intermediates with simplified process and enhanced supply chain reliability for pharmaceutical applications.
Patent CN108976238A enables high-yield chiral synthesis of bis-trifluoromethyl spirooxindoles with excellent stereoselectivity, offering reliable supply and cost reduction for pharmaceutical intermediates.
Patent CN111848322B enables high-yield resolution of axially chiral compounds with >96% ee through mild organocatalysis, ensuring reliable supply chain performance for pharmaceutical intermediates.
Patent CN102659494A enables high-purity oxindole synthesis with mild conditions, reducing lead time and manufacturing costs for pharmaceutical intermediates.
Solve toxic AIBN risks in oxindole synthesis. Iron-catalyzed method cuts costs, ensures 75% yield, and enables scalable production for pharma intermediates. Contact for COA/MSDS.